Lataa...
Characterization of a rat model of bortezomib‐induced painful neuropathy
BACKGROUND AND PURPOSE: Bortezomib (Velcade®) is a breakthrough treatment for multiple myeloma, significantly improving patient survival. However, its use is limited by painful neuropathy often resulting in dose reduction/cessation of first‐line treatment due to lack of treatment. The aim of this st...
Tallennettuna:
| Julkaisussa: | Br J Pharmacol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5727311/ https://ncbi.nlm.nih.gov/pubmed/28972650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14063 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|